AstraZeneca to invest $4.5 billion at Rivanna Futures, county says

Unidentified Speaker 2, an economic development representative, said AstraZeneca will invest $4,500,000,000 to build two manufacturing facilities at Rivanna Futures in what the speaker described as the company’s largest global manufacturing site.

The announcement, presented as the county’s major 2025 economic development milestone, follows adoption of a new county economic development strategic plan that the speaker said outlines priority industry sectors and workforce strategies. The speaker also cited related life-sciences activity including a Scientific project described as a $200,000,000, 200-job expansion and the Commonwealth Bio Accelerator as momentum contributors.

County officials also noted $11,000,000 in grant awards for the Rivanna Futures property that they said will fund utility extensions and preliminary earthwork in 2026. The county framed the investments as positioning Albemarle as a national hub for life-sciences manufacturing and as supporting job creation and tax-base diversification.

The county did not provide a detailed timeline for construction, specific employment start dates, or local incentives or tax agreements tied to the project in the remarks. The county said follow-up implementation work on utilities and earthwork will take place in 2026.